60 Degrees Pharmaceuticals
(NASDAQ) SXTP
60 Degrees Pharmaceuticals Financials at a Glance
Market Cap
$3.83M
Revenue (TTM)
$963.53K
Net Income (TTM)
$7.98M
EPS (TTM)
$-29.29
P/E Ratio
-0.05
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.47
Volume
3,262
Open
$1.51
Price
$1.47
Volume
3,262
Open
$1.51
Previous Close
$1.47
Daily Range
$1.43 - $1.53
52-Week Range
$1.29 - $17.68
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.47
Volume
3,262
Open
$1.51
Previous Close
$1.47
Daily Range
$1.43 - $1.53
52-Week Range
$1.29 - $17.68
SXTP News
SXTP: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 60 Degrees Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
3
CEO
Geoffrey S. Dow, PhD, MBA
Website
60degreespharma.comHeadquarters
Washington, DC 20036, US
SXTP Financials
Key Financial Metrics (TTM)
Gross Margin
19%
Operating Margin
-8%
Net Income Margin
-8%
Return on Equity
-152%
Return on Capital
-2%
Return on Assets
-1%
Earnings Yield
-20.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$3.83M
Shares Outstanding
2.47M
Volume
3.26K
Short Interest
0.00%
Avg. Volume
4.55M
Financials (TTM)
Gross Profit
$222.81K
Operating Income
$9.71M
EBITDA
$7.88M
Operating Cash Flow
$5.65M
Capital Expenditure
$181.11K
Free Cash Flow
$5.83M
Cash & ST Invst.
$3.39M
Total Debt
$155.89K
60 Degrees Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$437.60K
+223.4%
Gross Profit
$100.09K
-524.0%
Gross Margin
-22.87%
N/A
Market Cap
$3.83M
N/A
Market Cap/Employee
$1.28M
N/A
Employees
3
N/A
Net Income
$2.32M
-7.3%
EBITDA
$2.29M
-6.9%
Quarterly Fundamentals
Net Cash
$3.96M
-18.4%
Accounts Receivable
$674.04K
+108.2%
Inventory
$527.00K
+16.6%
Long Term Debt
$144.99K
-2.0%
Short Term Debt
$8.77K
+0.0%
Return on Assets
-1.19%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
$2.12M
-23.2%
Operating Cash Flow
$2.11M
-25.4%